Chemical-Induced Apoptosis: Formation of the Apaf-1 Apoptosome

Abstract Many environmental and therapeutic agents initiate apoptotic cell death by inducing the release of cytochrome c from the mitochondria, which activates Apaf-1 (apoptotic protease-activating factor-1). This large (˜130 kD) protein is a mammalian homologue of CED-4, an essential protein involved in programmed cell death in the nematode C. elegans. Cytochrome c activates Apaf-1, which oligomerizes to form an ˜700–1400-kDa caspase-activating complex known as the Apaf-1 apoptosome. Caspase-9, an initiator caspase, is then recruited to the complex by binding to Apaf-1 through CARD–CARD (caspase recruitment domain) interactions to form a holoenzyme complex. Subsequently, the Apaf-1/caspase-9 holoenzyme complex recruits the effector caspase-3 via an interaction between the active site cysteine in caspase-9 and the critical aspartate, which is the cleavage site for generating the large and small subunits of caspase-3 that constitute the activated form of caspase-3. This initiates the caspase cascade that is responsible for the execution phase of apoptosis. Intracellular levels of K+, XIAP an inhibitor of apoptosis protein, and at least two mitochondria1 released proteins, Smac/DIABLO and Omi/Htra 2 a serine protease, tightly regulate formation and function of the apoptosome. Thus, a number of physiological mechanisms ensure that the apoptosome complex is only fully assembled and functional when the cell is irrevocably committed to die. It is interesting that more recent studies show that a variety of small molecules can directly activate or inhibit caspase activation by interfering with the formation and function of the apoptosome complex. The cytotoxicity of many conventional chemotherapeutic drugs rests on their ability to induce apoptosome formation and apoptosis. Defects in this pathway can result in drug resistance, and the discovery that small molecules can directly activate or inhibit the apoptosome may provide new alternative treatments for cancer.

[1]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[2]  K. Cain,et al.  Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex. , 2000, Hepatology.

[3]  Jean-Claude Martinou,et al.  Breaking the mitochondrial barrier , 2001, Nature Reviews Molecular Cell Biology.

[4]  S. Srinivasula,et al.  Molecular Determinants of the Caspase-promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway* , 2000, The Journal of Biological Chemistry.

[5]  J. Liu,et al.  Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. , 2002, Cancer research.

[6]  M. Hengartner.  Death by Crowd Control , 1998, Science.

[7]  M. Grütter,et al.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. , 1999, Structure.

[8]  H. Horvitz,et al.  The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9 , 1998, Cell.

[9]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[10]  G. Walker,et al.  Caspase-3 cleaves Apaf-1 into an ∼30 kDa fragment that associates with an inappropriately oligomerized and biologically inactive ∼1.4 MDa apoptosome complex , 2001, Cell Death and Differentiation.

[11]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[12]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[13]  X. Liu,et al.  An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9* , 1999, The Journal of Biological Chemistry.

[14]  S. B. Bratton,et al.  Recruitment, activation and retention of caspases‐9 and ‐3 by Apaf‐1 apoptosome and associated XIAP complexes , 2001, The EMBO journal.

[15]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[16]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[17]  Xiaodong Wang,et al.  Cytochrome c Promotes Caspase-9 Activation by Inducing Nucleotide Binding to Apaf-1* , 2000, The Journal of Biological Chemistry.

[18]  R. Weichselbaum,et al.  Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3 , 2000, Oncogene.

[19]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[20]  P. Nicotera,et al.  Apoptosis and necrosis: different execution of the same death. , 1999, Biochemical Society symposium.

[21]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[22]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[23]  J. Kofron,et al.  Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway , 2003, Science.

[24]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[25]  G. Cohen,et al.  Elevated extracellular [K+] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. , 2001, The Biochemical journal.

[26]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP , 1999, Nature.

[27]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[29]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[30]  S. Srinivasula,et al.  The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.

[31]  Yuanming Hu,et al.  Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Cohen,et al.  Caspase Activation Involves the Formation of the Aposome, a Large (∼700 kDa) Caspase-activating Complex* , 1999, The Journal of Biological Chemistry.

[33]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[34]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[35]  J. Martinou,et al.  Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane , 2000, Molecular and Cellular Biology.

[36]  A. Chinnaiyan,et al.  ICE-LAP6, a Novel Member of the ICE/Ced-3 Gene Family, Is Activated by the Cytotoxic T Cell Protease Granzyme B* , 1996, The Journal of Biological Chemistry.

[37]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[38]  Emad S. Alnemri,et al.  Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1 , 1999, Nature.

[39]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[40]  G M Cohen,et al.  XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis , 2002, Cell Death and Differentiation.

[41]  D. Vaux,et al.  Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9 , 2001, The Journal of cell biology.

[42]  Emad S. Alnemri,et al.  A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[43]  G. Núñez,et al.  Role of cytochrome c and dATP/ATP hydrolysis in Apaf‐1‐mediated caspase‐9 activation and apoptosis , 1999, The EMBO journal.

[44]  Y. Tsujimoto,et al.  BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Kroemer,et al.  The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins , 1998, The Journal of experimental medicine.

[46]  P. Vandenabeele,et al.  The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet , 2002, Cell Death and Differentiation.

[47]  G M Cohen,et al.  Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. , 2000, The Journal of biological chemistry.

[48]  K. Schulze-Osthoff,et al.  The Adapter Protein Apoptotic Protease-activating Factor-1 (Apaf-1) Is Proteolytically Processed during Apoptosis* , 2001, The Journal of Biological Chemistry.

[49]  G. Cohen,et al.  The Apaf-1 apoptosome: a large caspase-activating complex. , 2002, Biochimie.

[50]  K. Wilson,et al.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. , 2000, Chemistry & biology.

[51]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[52]  Yigong Shi.  Apoptosome: the cellular engine for the activation of caspase-9. , 2002, Structure.

[53]  H. Horvitz,et al.  Genetic control of programmed cell death in the nematode Caenorhabditis elegans. , 1999, Cancer research.

[54]  H. Stennicke,et al.  Catalytic properties of the caspases , 1999, Cell Death and Differentiation.

[55]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[56]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[57]  Chaohong Sun,et al.  Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP* , 2003, The Journal of Biological Chemistry.

[58]  Y. Lazebnik,et al.  Caspase-9 and APAF-1 form an active holoenzyme. , 1999, Genes & development.

[59]  James A. Wells,et al.  Direct activation of the apoptosis machinery as a mechanism to target cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Guido Kroemer,et al.  Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.

[61]  A. Hunter,et al.  Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complex , 2001, Leukemia.

[62]  G. Cohen,et al.  Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. , 2000, Experimental cell research.

[63]  Gerard I. Evan,et al.  The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant , 2000, Nature Cell Biology.

[64]  S. Martin,et al.  The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. , 2001, Trends in biochemical sciences.

[65]  G. Cohen,et al.  Physiological Concentrations of K+ Inhibit Cytochrome c-dependent Formation of the Apoptosome* , 2001, The Journal of Biological Chemistry.

[66]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[67]  M. Murcko,et al.  Structure and mechanism of interleukin-1 beta converting enzyme. , 1994, Nature.

[68]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[69]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[70]  H. Nakayama,et al.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.

[71]  Geng Wu,et al.  Structural basis of IAP recognition by Smac/DIABLO , 2000, Nature.

[72]  P. Bucher,et al.  The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.

[73]  Yuri Lazebnik,et al.  Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction* , 2002, The Journal of Biological Chemistry.

[74]  A. Strasser,et al.  Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins , 2002, Cell Death and Differentiation.

[75]  Xiaodong Wang,et al.  Structural and biochemical basis of apoptotic activation by Smac/DIABLO , 2000, Nature.

[76]  D. Green,et al.  Stress management - heat shock protein-70 and the regulation of apoptosis. , 2001, Trends in cell biology.

[77]  G. Mclendon,et al.  A Mutational Epitope for Cytochrome c Binding to the Apoptosis Protease Activation Factor-1* , 2001, The Journal of Biological Chemistry.

[78]  T. Kuwana,et al.  The ‘harmless’ release of cytochrome c , 2000, Cell Death and Differentiation.

[79]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[80]  G. Bjursell,et al.  Nuclear and cytoplasmic pools of deoxyribonucleoside triphosphates in Chinese hamster ovary cells. , 1974, The Journal of biological chemistry.

[81]  G. Salvesen,et al.  Structural basis for the activation of human procaspase-7 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[83]  A. Chinnaiyan,et al.  ICE-LAP3, a Novel Mammalian Homologue of the Caenorhabditis elegans Cell Death Protein Ced-3 Is Activated during Fas- and Tumor Necrosis Factor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[84]  A. Strasser,et al.  BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. , 2002, Journal of cell science.

[85]  H. Horvitz,et al.  Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. , 2000, Science.

[86]  M. Jäättelä,et al.  Diarylurea Compounds Inhibit Caspase Activation by Preventing the Formation of the Active 700-Kilodalton Apoptosome Complex , 2003, Molecular and Cellular Biology.

[87]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[88]  Martin Schuler,et al.  Cytochrome C Maintains Mitochondrial Transmembrane Potential and Atp Generation after Outer Mitochondrial Membrane Permeabilization during the Apoptotic Process , 2001, The Journal of cell biology.

[89]  S. Srinivasula,et al.  Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. , 1998, Molecular cell.

[90]  Emad S. Alnemri,et al.  Crystal Structure of a Procaspase-7 Zymogen Mechanisms of Activation and Substrate Binding , 2001, Cell.

[91]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[92]  Emad S. Alnemri,et al.  Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.

[93]  R. Korneluk,et al.  XIAP, the guardian angel , 2001, Nature Reviews Molecular Cell Biology.

[94]  Francesco Cecconi,et al.  Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.

[95]  J. Downward,et al.  The Serine Protease Omi/HtrA2 Regulates Apoptosis by Binding XIAP through a Reaper-like Motif* , 2002, The Journal of Biological Chemistry.

[96]  A. Strasser,et al.  The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. , 1999, Molecular cell.

[97]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[98]  G. Cohen,et al.  Apoptotic death sensor: an organelle's alter ego? , 2001, Trends in pharmacological sciences.

[99]  D. Nicholson,et al.  Caspase structure, proteolytic substrates, and function during apoptotic cell death , 1999, Cell Death and Differentiation.

[100]  G. Walker,et al.  Caspase-3 cleaves Apaf-1 into an approximately 30 kDa fragment that associates with an inappropriately oligomerized and biologically inactive approximately 1.4 MDa apoptosome complex. , 2001, Cell death and differentiation.

[101]  G. Núñez,et al.  Expression and Functional Analysis of Apaf-1 Isoforms , 2000, The Journal of Biological Chemistry.

[102]  A. Strasser,et al.  Pro-Apoptotic Apoptosis Protease–Activating Factor 1 (Apaf-1) Has a Cytoplasmic Localization Distinct from Bcl-2 or Bcl-XL , 2000, The Journal of cell biology.

[103]  J. Kofron,et al.  Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. , 2003, Science.

[104]  M. Grütter,et al.  Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone* , 1997, The Journal of Biological Chemistry.

[105]  Junying Yuan,et al.  Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[106]  D. Baltimore,et al.  Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. , 1998, Science.

[107]  S. Srinivasula,et al.  Negative regulation of cytochrome c‐mediated oligomerization of Apaf‐1 and activation of procaspase‐9 by heat shock protein 90 , 2000, The EMBO journal.

[108]  O. Holmes.  The Guardian Angel , 1967 .

[109]  S. Cory,et al.  Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[110]  S. Srinivasula,et al.  Cytochrome c and dATP-mediated Oligomerization of Apaf-1 Is a Prerequisite for Procaspase-9 Activation* , 1999, The Journal of Biological Chemistry.

[111]  G. Cohen,et al.  The Inhibitor of Apoptosis Protein-Binding Domain of Smac Is Not Essential for Its Proapoptotic Activity , 2001, The Journal of cell biology.

[112]  K. Cain,et al.  Transforming growth factor‐β induces apoptosis in rat FaO hepatoma cells via cytochrome c Release and oligomerization of Apaf‐1 to form a ∼700‐kd apoptosome caspase–processing complex , 2000 .

[113]  J C Reed,et al.  Caspase-9 Can Be Activated without Proteolytic Processing* , 1999, The Journal of Biological Chemistry.

[114]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[115]  G. Mclendon,et al.  Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Martinou,et al.  Bax Is Present as a High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic Cells* , 2001, The Journal of Biological Chemistry.

[117]  R. Moritz,et al.  HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.

[118]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[119]  P. Hersey,et al.  The chemoresistance of human malignant melanoma: an update. , 1999, Melanoma research.

[120]  Seamus J. Martin,et al.  Regulation of Apoptotic Protease Activating Factor-1 Oligomerization and Apoptosis by the WD-40 Repeat Region* , 1999, The Journal of Biological Chemistry.